Company / EPS (Diluted)
Vera Therapeutics, Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.66
FY2025
5-year range
-$4.66 / -$2.25
FY2021-FY2025
Trend
-69.5%
vs FY2024
Sector context
#172 of 204
Health Care
What the data says
Vera Therapeutics, Inc.'s eps (diluted) of $-4.66 is lower than 84% of companies in the Health Care sector (FY2025). Declined from $-2.25 to $-4.66 over the past 2 years.
Based on SEC 10-K filings.
-4.66 in FY2025.
Declined from $-2.25 to $-4.66 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 204This company -$4.66 Sector average -$0.89
▼
-425.8% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 69.5% year-over-year.
- Ranks #172 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.66 | -69.5% |
| FY2024 | -$2.75 | -22.2% |
| FY2023 | -$2.25 | +32.8% |
| FY2022 | -$3.35 | -37.9% |
| FY2021 | -$2.43 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026